ESR1 and breast carcinoma: In a breast cancer cohort, Lou et al.21 demonstrated an elevated expression pattern of PTTG3P and discovered that PTTG3P expression correlated negatively with estrogen receptor (ER) and progesterone receptor (PR) status.